Fresenius Kabi Launches Epinephrine Injection, USP
Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of Epinephrine for U.S. customers, broadening accessibility to a critical medication.
Understanding Epinephrine Injection, USP
Epinephrine Injection, USP is a vital prescription medication tailored for various uses in medical emergencies. Primarily, it is employed to elevate mean arterial blood pressure among adults grappling with hypotension due to septic shock. Additionally, it plays a crucial role in managing severe allergic reactions, including anaphylaxis, and facilitates mydriasis during eye-related surgical procedures.
Commitment to Quality Care
"Fresenius Kabi is delighted to bring Epinephrine Injection to the U.S. market, reiterating our unwavering dedication to quality and cost-effective care for clinicians and their patients. This is integral to our broader #FutureFresenius vision," stated Arunesh Verma, president of Fresenius Kabi Region U.S.
Investment in Production and Domestic Manufacturing
Fresenius Kabi's commitment to enhancing healthcare extends beyond product offerings; the company has made substantial investments nearing $1 billion aimed at advancing and modernizing its production and distribution capabilities across the United States. Notably, over 70 percent of the pharmaceutical units they distribute are comprised of medications that the FDA categorizes as essential, ensuring that critical treatments remain accessible.
Indications and Usage of Epinephrine
The indications for Epinephrine Injection, USP are clearly defined. This medication serves multiple pivotal roles:
- It assists in augmenting arterial blood pressure in adult patients facing hypotension related to septic shock.
- It is crucial for the immediate management of allergic reactions, particularly in cases of anaphylaxis.
- It is effective for inducing and maintaining mydriasis during ocular surgical interventions.
Safety Considerations
Understanding the safety of Epinephrine Injection is essential. Some key safety information includes:
- Patients must be monitored for signs of acute severe hypertension.
- There is a risk associated with extravasation; care should be taken to avoid injecting into certain areas, including the buttocks and fingers, to prevent necrosis.
- Intravenous administration may lead to potential pulmonary edema, which necessitates immediate medical attention.
- Patients with existing heart conditions may experience heightened risks of arrhythmias or angina with epinephrine use.
Common side effects may encompass headaches, anxiety, restlessness, trembles, dizziness, and more severe reactions like arrhythmias and potential increases in blood pressure leading to complications.
Report and Manage Adverse Reactions
Fresenius Kabi encourages proactive communication regarding any suspected adverse reactions associated with Epinephrine Injection. Individuals can reach out directly to Fresenius Kabi USA or contact the FDA for additional guidance.
About Fresenius Kabi
As a part of a global health landscape, Fresenius Kabi remains dedicated to improving patient care through innovative products and technologies. This commitment extends through a dynamic portfolio aimed at addressing the needs of patients with both critical and chronic conditions. With over 43,000 employees dedicated to its mission and operations in more than 100 countries, Fresenius Kabi is not merely a healthcare provider but a partner in patient health management.
In the Biopharma sector, Fresenius Kabi delivers state-of-the-art biosimilars tailored for conditions like autoimmune diseases and cancer. Furthermore, their extensive clinical nutrition solutions ensure optimal nutritional support for patients, distinguishing them as the only entity that provides both enteral and parenteral product lines. Moreover, Fresenius Kabi excels in the MedTech domain, offering essential infusion pumps and critical care devices.
Vision for the Future
Through initiatives like Vision 2026 and the #FutureFresenius strategy, Fresenius Kabi aims to innovate and expand its presence on a global scale, continually enhancing patient care while fostering sustainable value for all stakeholders involved.
Frequently Asked Questions
What is Epinephrine Injection used for?
Epinephrine Injection is primarily used to treat hypotension in septic shock, emergency allergic reactions, and to induce mydriasis in eye surgeries.
Why has Fresenius Kabi launched Epinephrine Injection?
This launch reflects Fresenius Kabi's ongoing commitment to provide quality, essential medications to healthcare providers and patients in the U.S.
How is Fresenius Kabi expanding its production facilities?
Fresenius Kabi has invested nearly $1 billion to elevate and modernize its pharmaceutical production and distribution capabilities in the U.S.
Where can I report adverse reactions to Epinephrine Injection?
Adverse reactions can be reported to Fresenius Kabi USA directly or via the FDA at their official contact numbers.
What is Fresenius Kabi’s commitment to patient care?
Fresenius Kabi is dedicated to improving patient care through innovative healthcare solutions, emphasizing quality, safety, and accessibility.
